Naringenin adds to the protective effect of l-arginine in monocrotaline-induced pulmonary hypertension in rats: Favorable modulation of oxidative stress, inflammation and nitric oxide

European Journal of Pharmaceutical Sciences

Volumn 62, Issue , 2014, Pages 161-170

  Ahmed, Lamiaa A ^a   Obaid, Al Arqam Z ^a   Zaki, Hala F ^a   Agha, Azza M ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

l arginine; Monocrotaline; Naringenin; Pulmonary hypertension

Indexed keywords

ARGININE; CASPASE 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; MONOCROTALINE; MYELOPEROXIDASE; NARINGENIN; NITRATE; NITRIC OXIDE; NITRITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; FLAVANONE DERIVATIVE; NOS2 PROTEIN, RAT; NOS3 PROTEIN, RAT; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENTIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; HEART RIGHT VENTRICLE; HISTOPATHOLOGY; INFLAMMATION; LIPID PEROXIDATION; LUNG WEIGHT; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; TREATMENT DURATION; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; HYPERTENSION, PULMONARY; METABOLISM; PATHOLOGY; PULMONARY ARTERY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARGININE; CASPASE 3; FLAVANONES; HYPERTENSION, PULMONARY; INFLAMMATION; MALE; MONOCROTALINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PEROXIDASE; PULMONARY ARTERY; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903158906     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2014.05.011     Document Type: Article

References (62)

1. S. Aggarwal, C.M. Gross, S. Sharma, J.R. Fineman, and S.M. Black Reactive oxygen species in pulmonary vascular remodeling Compr. Physiol. 3 2013 1011 1034
2. F. Akhavein, E.J. St Michel, E. Seifert, and C.V. Rohlicek Decreased left ventricular function, myocarditis, and coronary arteriolar medial thickening following monocrotaline administration in adult rats J. Appl. Physiol. 103 2007 287 295 (Pubitemid 47092303)
3. N. Ambalavanan, G. Mariani, A. Bulger, and J.B. Philips Role of nitric oxide in regulating neonatal porcine pulmonary artery smooth muscle cell proliferation Biol. Neonate 76 1999 291 300 (Pubitemid 29473710)
4. S.S. Arcot, D.W. Lipke, M.N. Gillespie, and J.W. Olsen Alterations of growth factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension Biochem. Pharm. 46 1993 1086 1091 (Pubitemid 23280552)
5. S.M. Aziz, M. Toborek, B. Hennig, M.P. Mattson, H. Guo, and D.W. Lipke Oxidative stress mediates monocrotaline-induced alterations in tenascin expression in pulmonary artery endothelial cells Int. J. Biochem. Cell Biol. 29 1997 775 787 (Pubitemid 27323166)
6. P.A. Baeuerle IκB-NF-κB structures: at the interface of inflammation control Cell 95 1998 729 731 (Pubitemid 29014451)
7. J.T. Berg, E.C. Breen, Z. Fu, O. Mathieu-Costello, and J.B. West Alveolar hypoxia increases gene expression of extracellular matrix proteins and platelet-derived growth factor-B in lung parenchyma Am. J. Respir. Crit. Care Med. 158 1998 1920 1928 (Pubitemid 29008834)
8. E. Beutler, O. Duron, and B.M. Kelly Improved method for the determination of blood glutathione J. Lab. Clin. Med. 61 1963 882 888
9. A. Bhargava, A. Kumar, N. Yuan, M.H. Gewitz, and R. Mathew Monocrotaline induces interleukin-6 mRNA expression in rat lungs Heart Dis. 1 1999 126 132
10. R.H. Böger, and E.S. Ron l-arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor Altern. Med. Rev. 10 2005 14 23 (Pubitemid 40397188)
11. P.P. Bradley, D.A. Priebat, R.D. Christensen, and G. Rothstein Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J. Invest. Dermatol. 78 1982 206 209 (Pubitemid 12171880)
12. J.A. Buege, and S.D. Aust Microsomal lipid peroxidation Methods Enzymol. 52 1978 302 310
13. S.Y. Chan, and J. Loscalzo Pathogenic mechanisms of pulmonary arterial hypertension J. Mol. Cell. Cardiol. 44 2008 14 30
14. H.T. Chung, H.O. Pae, B.M. Choi, T.R. Billiar, and Y.M. Kim Nitric oxide as a bioregulator of apoptosis Biochem. Biophys. Res. Commun. 282 2001 1075 1079
15. L.A. Coburn, X. Gong, K. Singh, M. Asim, B.P. Scull, M.M. Allaman, C.S. Williams, M.J. Rosen, M.K. Washington, D.P. Barry, M.B. Piazuelo, R.A.J. Casero, R. Chaturvedi, Z. Zhao, and K.T. Wilson l-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis PLoS One 7 2012 e33546
16. F. De Nigris, L.O. Lerman, S.W. Ignarro, G. Sica, A. Lerman, W. Palinski, L.J. Ignarro, and C. Napoli Beneficial effects of antioxidants and l-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress Proc. Natl. Acad. Sci. 100 2003 1420 1425 (Pubitemid 36184017)
17. P. Dorfmuller, F. Perros, K. Balabanian, and M. Humbert Inflammation in pulmonary arterial hypertension Eur. Respir. J. 22 2003 358 363 (Pubitemid 36987011)
18. F. Fallahi, M. Roghani, and S. Moghadami Citrus flavonoid naringenin improves aortic reactivity in streptozotocin-diabetic rats Ind. J. Pharmacol. 44 2012 382 386
19. R.E. Girgis, H.C. Champion, G.B. Diette, R.A. Johns, S. Permutt, and J.T. Sylvester Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy Am. J. Respir. Crit. Care Med. 172 2005 352 357 (Pubitemid 41026146)
20. A.C. Grobe, S.M. Wells, E. Benavidez, P. Oishi, A. Azakie, J.R. Fineman, and S.M. Black Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase Am. J. Physiol. Lung Cell. Mol. Physiol. 290 2006 1069 1077
21. P.M. Hassoun, L. Mouthon, J.A. Barberà, S. Eddahibi, S.C. Flores, F. Grimminger, P.L. Jones, M.L. Maitland, E.D. Michelakis, N.W. Morrell, J.H. Newman, M. Rabinovitch, R. Schermuly, K.R. Stenmark, N.F. Voelkel, J.X. Yuan, and M. Humbert Inflammation, growth factors, and pulmonary vascular remodeling J. Am. Coll. Cardiol. 54 2009 S10 S19
22. I.R. Henkens, K.T. Mouchaers, H.W. Vliegen, W.J. van der Laarse, C.A. Swenne, A.C. Maan, H.H. Draisma, I. Schalij, E.E. van der Wall, M.J. Schalij, and A. Vonk-Noordegraaf Early changes in rat hearts with developing pulmonary arterial hypertension can be detected with three-dimensional electrocardiography Am. J. Physiol. Heart Circ. Physiol. 293 2007 1300 1307
23. T. Henriques-Coelho, J. Correia-Pinto, J.R. Roncon-Albuquerque, M.J. Baptista, A.P. Lourenco, S.M. Oliveira, A. Brandao-Nogueira, A. Teles, J.M. Fortunato, and A.F. Leite-Moreira Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension Am. J. Physiol. Heart Circ. Physiol. 287 2004 2885 2890
24. M.H. Hessel, P. Steendijk, B. den Adel, C.I. Schutte, and A. van der Laarse Characterization of right ventricular function after monocrotaline- induced pulmonary hypertension in the intact rat Am. J. Physiol. Heart Circ. Physiol. 291 2006 2424 2430
25. T.K. Jeffery, and J.C. Wanstall Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension Pharmacol. Ther. 92 2001 1 20 (Pubitemid 34032020)
26. S.M. Jeon, H.K. Kim, H.J. Kim, G.M. Do, T.S. Jeong, Y.B. Park, and M.S. Choi Hypocholesterolemic and antioxidative effects of naringenin and its two metabolites in high-cholesterol fed rats Transl. Res. 149 2007 15 21 (Pubitemid 44969644)
27. P. Jurasz, D. Courtman, S. Babaie, and D.J. Stewart Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials Pharmacol. Ther. 126 2010 1 8
28. F. Kamezaki, H. Tasaki, K. Yamashita, M. Tsutsui, S. Koide, S. Nakata, A. Tanimoto, M. Okazaki, Y. Sasaguri, T. Adachi, and Y. Otsuji Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats Am. J. Respir. Crit. Care Med. 177 2008 219 226
29. S. Kannappan, N. Palanisamy, and C.V. Anuradha Suppression of hepatic oxidative events and regulation of eNOS expression in the liver by naringenin in fructose-administered rats Eur. J. Pharmacol. 645 2010 177 184
30. H.S. Koo, K.C. Kim, and Y.M. Hong Gene expressions of nitric oxide synthase and matrix metalloproteinase-2 in monocrotaline-induced pulmonary hypertension in rats after bosentan treatment Korean Circ. J. 41 2011 83 90
31. K. Leineweber, T. Seyfarth, G. Abraham, H.P. Gerbershagen, I. Heinroth-Hoffmann, K. Ponicke, and O.E. Brodde Cardiac β-adrenoceptor changes in monocrotaline-treated rats: differences between membrane preparations from whole ventricles and isolated ventricular cardiomyocytes J. Cardiovasc. Pharmacol. 41 2003 333 342 (Pubitemid 36255292)
32. F. Liang, E. Gao, L. Tao, H. Liu, Y. Qu, T.A. Christopher, B.L. Lopez, and X.L. Ma Critical timing of l-arginine treatment in post-ischemic myocardial apoptosis-role of NOS isoforms Cardiovasc. Res. 62 2004 568 577 (Pubitemid 38648971)
33. D.W. Lipke, S.S. Arcot, M.N. Gillespie, and J.W. Olson Temporal alterations in specific basement membrane components in lungs from monocrotaline treated rats Am. J. Respir. Cell Mol. Biol. 9 1993 418 428
34. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
35. E.V. Margaritis, A.E. Yanni, G. Agrogiannis, N. Liarakos, A. Pantopoulou, I. Vlachos, A. Papachristodoulou, P. Korkolopoulou, E. Patsouris, M. Kostakis, D.N. Perrea, and A. Kostakis Effects of oral administration of (l)-arginine, (L)-NAME and allopurinol on intestinal ischemia/reperfusion injury in rats Life Sci. 88 2011 1070 1076
36. J. Mattana, and P.C. Singhal l-arginine supplementation antagonizes the effects of angiotensin II and endothelin 1 on mesangial cell proliferation Cell. Physiol. Biochem. 5 1995 176 192
37. S. Mehta, D.J. Stewart, D. Langleben, and R.D. Levy Short-term pulmonary vasodilation with l-arginine in pulmonary hypertension Circulation 92 1995 1539 1545
38. S.D. Mershiba, M.V. Dassprakash, and S.D. Saraswathy Protective effect of naringenin on hepatic and renal dysfunction and oxidative stress in arsenic intoxicated rats Mol. Biol. Rep. 40 2013 3681 3691
39. B. Meyrick, W. Gamble, and L. Reid Development of crotalaria pulmonary hypertension: hemodynamic and structural study Am. J. Physiol. 239 1980 H692 H702
40. K.M. Miranda, M.G. Espey, and D.A. Wink A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite Nitric oxide Biol. Chem. 5 2001 62 71 (Pubitemid 34146173)
41. Y. Mitani, K. Maruyama, and M. Sakurai Prolonged administration of l-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats Circulation 96 1997 689 697 (Pubitemid 27329452)
42. A. Molteni, W.F. Ward, C.H. Tsào, and N.H. Solliday Monocrotaline pneumotoxicity in mice Virchows Arch. B. Cell. Pathol. Incl. Mol. Pathol. 57 1989 149 155 (Pubitemid 19170570)
43. N. Nagaya, M. Uematsu, H. Oya, N. Sato, F. Sakamaki, S. Kyotani, K. Ueno, N. Nakanishi, M. Yamagishi, and K. Miyatake Short-term oral administration of l-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension Am. J. Respir. Crit. Care Med. 163 2001 887 891 (Pubitemid 32275859)
44. P. Oishi, A. Grobe, E. Benavidez, B. Ovadia, C. Harmon, G.A. Ross, K. Hendricks-Munoz, J. Xu, S.M. Black, and J.R. Fineman Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension: a role for superoxide and peroxynitrite in the intact lamb Am. J. Physiol. Lung Cell. Mol. Physiol. 290 2006 L359 L366
45. Z.J. Ou, W. Wei, D.D. Huang, W. Luo, D. Luo, Z.P. Wang, X. Zhang, and J.S. Ou l-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats Am. J. Physiol. Endocrinol. Metab. 298 2010 E1131 E1139
46. S. Oyadomari, K. Takeda, M. Takiguchi, T. Gotoh, M. Matsumoto, I. Wada, S. Akira, E. Araki, and M. Mori Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway Proc. Natl. Acad. Sci. 98 2001 10845 10850 (Pubitemid 32878707)
47. E.I. Ozturk, and S. Uma Effects of atorvastatin and l-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats J. Cardiovasc. Pharmacol. 56 2010 498 505
48. H.Y. Park, G.Y. Kim, and Y.H. Choi Naringenin attenuates the release of pro-inflammatory mediators from lipopolysaccharide-stimulated BV2 microglia by inactivating nuclear factor-κB and inhibiting mitogen-activated protein kinases Int. J. Mol. Med. 30 2012 204 210
49. S. Pullamsetti, S. Krick, H. Yilmaz, H.A. Ghofrani, C. Schudt, N. Weissmann, B. Fuchs, W. Seeger, F. Grimminger, and R.T. Schermuly Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration Respir. Res. 6 2005 128
50. S. Sasaki, M. Asano, T. Ukai, N. Nomura, K. Maruyama, T. Manabe, and A. Mishima Nitric oxide formation and plasma l-arginine levels in pulmonary hypertensive rats Respir. Med. 98 2004 205 212 (Pubitemid 38262653)
51. R.T. Schermuly, H.A. Ghofrani, M.R. Wilkins, and F. Grimminger Mechanisms of disease: pulmonary arterial hypertension Nat. Rev. Cardiol. 8 2011 443 455
52. D. Shao, J.E.S. Park, and S.J. Wort The role of endothelin-1 in the pathogenesis of pulmonary arterial hypertension Pharmacol. Res. 63 2011 504 511
53. B.T. Steffen, S.J. Lees, and F.W. Booth Anti-TNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia J. Appl. Physiol. 105 2008 1950 1958
54. C.K. Sun, F.Y. Lee, J.J. Sheu, C.M. Yuen, S. Chua, S.Y. Chung, H.T. Chai, Y.T. Chen, Y.H. Kao, L.T. Chang, and H.K. Yip Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats J. Pharmacol. Exp. Ther. 330 2009 718 726
55. X. Tan, W.D. Sun, J.C. Li, J.Q. Pan, Y.J. Liu, J.Y. Wang, and X.L. Wang l-arginine prevents reduced expression of endothelial nitric oxide synthase (NOS) in pulmonary arterioles of broilers exposed to cool temperatures Vet. J. 173 2007 151 157
56. P. Tripathi, and S. Pandey l-arginine attenuates oxidative stress condition during cardiomyopathy Ind. J. Biochem. Biophys. 50 2013 99 104
57. S. Umar, P. Steendijk, D.L. Ypey, D.E. Atsma, E.E. van der Wall, M.J. Schalij, and L.A. van der Novel approaches to treat experimental pulmonary arterial hypertension: a review J. Biomed. Biotechnol. 2010 2010 1 11
58. L. Virág, D.J. Marmer, and C. Szabó Crucial role of apopain in the peroxynitrite-induced apoptotic DNA fragmentation Free Radic. Biol. Med. 25 1998 1075 1082 (Pubitemid 28558334)
59. S. Wallner, A. Hermetter, B. Mayer, and T.C. Wascher The alpha-amino group of l-arginine mediates its antioxidant effect Eur. J. Clin. Invest. 31 2001 98 102 (Pubitemid 32199900)
60. J. Wang, Z. Yang, L. Lin, Z. Zhao, Z. Liu, and X. Liu Protective effect of naringenin against lead-induced oxidative stress in rats Biol. Trace Elem. Res. 146 2012 354 359
61. F.L. Yen, T.H. Wu, L.T. Lin, T.M. Cham, and C.C. Lin Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl (4)-induced acute liver failure Pharm. Res. 26 2009 893 902
62. J. Yu, L.M. Wang, R.L. Walzem, E.G. Miller, L.M. Pike, and B.S. Patil Antioxidant activity of citrus limonoids, flavonoids, and coumarins J. Agric. Food Chem. 53 2005 2009 2014 (Pubitemid 40395766)